Dialectical Behavior Therapy for Adults With Autism Spectrum Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-16

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dialectical Behavior Therapy (DBT; Linehan, 1993) effectively diminishes emotion dysregulation and self-harm behaviors in a number of disorders. However, to our knowledge, no studies have investigated the efficacy of DBT to treat emotional dysregulation associated with self-harm and suicidal behaviors in adults with ASD without intellectual disability. This randomized controlled study trial aims to assess the efficacy of a 5-month DBT intervention in adults with ASD without intellectual disability who present with self-harm and/or suicidal behaviors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development of Self-regulation by Dialectial Behavioural Therapy in Adults With Autism

NCT05502484

Autism Spectrum Disorder Regulation, Self

UNKNOWN NA

DBT Skill Training for Autistic Adults With Difficulties in Emotion Regulation.

NCT07021274

Difficulties of Emotion Regulation Self-harm Behavior Autism Spectrum Disorder

NOT_YET_RECRUITING NA

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

NCT05398250

Suicidal Ideation Suicidal and Self-injurious Behavior Suicide +1 more

RECRUITING NA

Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency

NCT02747056

Autism Spectrum Disorders

COMPLETED NA

UCB Stem Cells for Autism Spectrum Disorders

NCT04710810

Autism Spectrum Disorder

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dialectical Behavior Therapy (DBT)

Psychotherapy (duration 5 months) will begin within a maximum of 1 month (the time to set up the group) and will be accompanied by individual follow-up. Evaluations will be carried out within 6 months of the end of the psychotherapy in order to measure its effects.

Group Type EXPERIMENTAL

Dialectical Behavior Therapy (DBT)

Intervention Type OTHER

Dialectical Behavior Therapy (DBT)

Therapy

waiting list for 5 months before starting psychotherapy (duration 5 months). During this time, the patient can continue your usual therapeutic follow-ups. Likewise, assessments will be carried out within 6 months after the end of the psychotherapy in order to measure its effects. the patient will thus benefit from DBT regardless of the group.

Group Type OTHER

Dialectical Behavior Therapy (DBT)

Intervention Type OTHER

Dialectical Behavior Therapy (DBT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dialectical Behavior Therapy (DBT)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years old
* ASD diagnosis according to the DSM-5
* IQ ≥ 70
* Suicidal ideas, suicidal attempts and/or self-harm behaviors 6 months prior to the inclusion
* Able to understand and consent to the research aims
* Membership in a health insurance fund